Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease - PubMed
The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical...
pubmed.ncbi.nlm.nih.gov
Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease - PubMed
The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical...
pubmed.ncbi.nlm.nih.gov
¿Alguien les está explicando esto a los que se están vacunando? ¿Si se da esta circunstancia este otoño cómo será abordado oficialmente?
Más les vale a los vacunados reforzar todo lo que puedan su sistema inmunológico para evitar males mayores este otoño.
FUENTE
Julio Ariza
https://pubmed.ncbi.nlm.nih.gov/33113270/ Estudio publicado por el NIH (National Institute of Health en EEUU). En cuyos resultados dice textualmente: Resultados del estudio: Las vacunas contra el COVID-19 diseñadas para provocar anticuerpos neutralizantes pueden sensibilizar a los receptores...
t.me